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PURPOSE. Myopia is a common vision problem affecting almost
one third of the world’s population. It can occur as an isolated
genetic condition or be associated with other anomalies and/or
syndromes. Seventeen myopia loci have been identified on
various chromosomes; however, no specific gene mutations
have yet been identified.
METHODS. Two large multigeneration Asian Indian pedigrees
(UR006 and UR077) with isolated, nonsyndromic myopia were
studied, in which the condition appeared to segregate as an
X-linked recessive trait (MYP1; MIM 310460). The degree of
myopia was variable in both families, ranging from 6 to 23
D (mean, –8.48 D) with the majority 7.0 D. To map the
myopia locus in these families, polymorphic microsatellite
markers covering the entire X chromosome were used in
linkage analyses performed on 42 genomic DNA samples (13
affected and 29 normal) from both families.
RESULTS. Marker DXYS154, which is located within the pseu-
doautosomal region in distal Xq28 (PAR2; pseudoautosomal
region 2), gave a combined maximum LOD score of 5.3 at  
0 under an autosomal recessive model. Other markers in the
region (near but not within the PAR2 region) that showed no
recombination with the phenotype in both the families in-
cluded DXS1108, DXS8087, and F8i13.
CONCLUSIONS. Observation of recombination in family UR006
refined the disease locus to a 1.25-Mb region flanked by the
proximal marker DXS1073 and distal marker DXYS154. Muta-
tion search in exons and splice junctions of candidate genes
CTAG2, GAB3, MPP1, F8Bver, FUNDC2, VBP1, RAB39B,
CLIC2, TMLHE, SYBL, IL9R, SPRY3, and CXYorf1 did not
detect a pathogenic or predisposing variant. (Invest Ophthal-
mol Vis Sci. 2011;52:6814–6819) DOI:10.1167/iovs.10-6815
Myopia (MYP), generally known as near-sightedness, is thenatural refractive state of having a focal point in front of
the retina: Near objects are in focus, but distant objects appear
out of focus. The condition is due to excessive elongation of
the eyeball in the axial dimension.1 It is generally categorized
as mild (0–1.5 D), moderate (1.5–6.0 D), and high-grade (6.0
D). Pathologic myopia (8.0 D) is often associated with retinal
disease, cataract, glaucoma, and choroidal neovascularization,
and the risk of threats to vision can also occur in patients with
moderate- and/or high-grade myopia.2 There are a few factors
that have been hypothesized as potential environmental risk
factors for myopia, but to date, none have been conclusively
proven, including night lighting,3,4 excessive nearwork,5 and
certain occupations.6 The prevalence of myopia is often pre-
sumed to be much higher, in that exact population-based data
are not available. In general, high-grade myopia has a preva-
lence of 2.8% to 9.1%7,8; however, it is specific to the age and
sex of the individual ethnic population. The prevalence of
X-linked myopia is uncertain, as there is a paucity of data due
to a very low number of published reports of families with
X-linked myopia.9–13
Several genome-wide linkage studies conducted using multi-
plex MYP families of different ethnic origins showed evidence of
linkage at 17 loci for either high- or low-grade myopia (MYP) on
Xq28 (MYP1 [MIM 310460]), 18p11.31 (MYP2 [MIM 160700]),
12q21-q23 (MYP3 [MIM 603221]), 17q21-q22 (MYP5 [MIM
608474]), 22q12 (MYP6 [MIM 608908]), 11p13 (MYP7
[MIM609256]), 3q26 (MYP8 [MIM 609257]), 4q12 (MYP9 [MIM
609258]), 8p23 (MYP10 [MIM 609259]), 4q22-q27 (MYP11 [MIM
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609994]), 2q37.1 (MYP12 [MIM 609995]), Xq23-q25 (MYP13
[MIM 300613]), 1p36 (MYP14 [MIM 610320]), 10q21.1 (MYP15
[MIM 612717]), 5p15.33-p15.2 (MYP16 [MIM 612554]), 7p15
(MYP17 [MIM 608367]), and 14q22.1-q24.2 (MYP18; [MIM
613626]).9,10,14–25 In addition, three independent association and
linkage studies of different populations have identified myopia
loci at 11q24.1, 15q14, and 15q25, respectively.15,16 26–28 In-
creased incidence of gene polymorphism associated with patho-
logic myopia was reported recently16,17,29–31; however, no spe-
cific gene mutations or pathogenic causative genomic
variations have yet been identified for these loci. The ma-
jority of these studies were performed on autosomal domi-
nant MYP families. X-linked myopia may occur as an isolated
genetic anomaly or it may be associated with various other
anomalies, such as night blindness,32–35 cone–rod dysfunc-
tion,36 albinism,37 Aland Island eye disease,38,39 and blue
cone monochromacy,40 combined with astigmatism, im-
paired vision, hypoplasia of the optic nerve heads, and
deuteranopia (color blindness).9,12 Although most reports
have associated X-linked myopia with other anomalies, a few
have suggested that it is isolated.11,41,42
We report MYP1 locus homogeneity to the previously
defined Xq28 region9 in two large multigeneration Asian
Indian families with nonsyndromic high-grade myopia
(UR006 and UR077), and the exclusion of potential candi-
date genes located in this region. Recombination in family
UR006 refined the previously mapped MYP1 disease locus to
1.25 Mb flanked by the proximal marker DXS1073 and
distal marker DXYS154. Thirteen positional candidate genes
were excluded by direct sequence analysis of known exons
and splice junctions. The present study represents the first
confirmation of locus homogeneity of the MYP1 locus for
nonsyndromic X-linked high-grade myopia without any as-
sociated anomalies to Xq28.
MATERIALS AND METHODS
Family UR006
The six-generation pedigree UR006 with isolated, nonsyndromic, high-
grade myopia was from Gujarat, in western India. The original pedigree
consisted of 60 persons with 10 affected individuals (Fig. 1A). The age
at onset ranged from 4 to 6 years, and the degree of myopia among
affected family members was variable, ranging from 6 to 23 D
(mean, 9.53 D), with the majority 8.0 D.
Family UR077
This five-generation pedigree UR077 is from the southern state of
India, Andhra Pradesh, and consists of 22 individuals, with 3 male
members affected with myopia (Fig. 1B). The age at onset was
between 4 and 12 years, and the degree of myopia was between
6.00 to 9.5 D (mean, 7.43).
Fifty-four individuals from both the pedigrees who joined in the
study were followed up for several years by RS and VVR. To exclude
those with a known syndromic form of myopia, such as Marfan syn-
drome, Stickler syndrome, or Knobloch syndrome, a detailed physical
examination was performed and medical and ophthalmic histories
were acquired; those with other known ocular or systemic diseases
were also excluded. Detailed ophthalmic examinations were con-
ducted by experienced ophthalmologists (RS and VVR) for each pa-
tient included in the study, including visual acuity, slit lamp, intraoc-
ular pressure, axial length, color vision testing, and funduscopic
examination. Electroretinogram (ERG) testing was performed in se-
lected affected individuals. In all patients, individual eye refraction was
performed (RT5100; Nidek, Gamagori, Japan; Fig. 2). For the genotyp-
ing analysis, the minimal requirements of phenotype for a subject was
considered to be high-grade myopia if the refraction error in the either
eye was 6 D or below and a maximum age at onset was 4 to 12 years.
In both the pedigrees, only male members were affected and the
degree of myopia increased with advance age. The affected subjects
had high-grade myopia, and the carrier females had no functional or
structural visual problems. No other associated visual anomalies, spe-
cifically color vision defect or night blindness, were present in any
member of these pedigrees. No male-to-male transmission was ob-
served in either family and none of the female members was affected,
suggestive of an X-linked recessive mode of inheritance with full
penetrance. The research adhered to the tenets of the Declaration of
Helsinki. Informed consent was obtained from all subjects who partic-
ipated in the study, and their blood samples were collected for the
genetic studies. Both are unrelated families of different geographic
regions, live in urban areas, and are of higher socioeconomic condition
than the Indian average. None of the affected individuals had a history
of occupational exposures none were involved in any hazardous oc-
cupations.
Linkage Analysis
Genomic DNA was purified from peripheral blood samples with a
DNA extraction kit (Gentra Systems, Inc., Minneapolis, MN). In the
present study, we used 42 samples including 13 affected and 29
normal individuals from both the families, numbered under each
individual in the pedigrees (Fig. 1). Initially, we presumed that the
phenotype in both the pedigrees (UR006 and UR077) would be
allelic to the known MYP1 locus on Xq28. To test this assumption,
we performed linkage analysis with the 25 microsatellite markers
previously used for genetic analysis of the candidate genomic re-
gions, including the markers that covered the entire X-chromosome.
These markers were selected from the Marshfield, Genethon, and
CHLC collection (NIH/CEPH Collaborative Mapping Group,
1992).43,44 One oligonucleotide primer of each marker was labeled
with [32P]ATP, with T4 polynucleotide kinase. PCR was performed
from 120 ng of genomic DNA in a total volume of 15-L mixture per
reaction containing 0.4 pM of labeled forward primer, 2.6 pM of
unlabeled reverse primer, 1.3 M of each dNTP, and 0.25 U Taq
polymerase (Pharmacia, San Diego, CA). PCR products were sepa-
rated by electrophoresis in a 6% denaturing urea/polyacrylamide
gel. Genotyping was performed as previously described.45
Family information and marker genotypes were stored in a
pedigree program (Cyrillic 2.1; Cherwell Software, Colorado Spring,
CO). Statistical analysis was performed on the basis of an X-linked
recessive trait for X chromosome and recessive for PAR2 (pseudo-
autosomal region 2) with 100% penetrance. For all markers, the
allele frequencies were kept equal, and the gene frequency was set
to 0.00001. Maximum LOD scores (Zmax) were calculated for each
marker by the use of the ILINK, MLINK, and LINKMAP programs of
LINKAGE ver. 5.246 and FASTLINK ver. 3.0.47 Two-point and mul-
tipoint analysis for both X-chromosome and PAR2 were performed
separately as described.48,49
Candidate Gene Eye Tissue Expression Studies
For reverse transcription–polymerase chain reaction (RT-PCR), total
RNA from sclera, cornea, optic nerve, and retina was extracted from
pooled human donor eyes (Pennsylvania Lions Eye Bank, Philadel-
phia) using an extraction reagent (TRIzol; Invitrogen, Carlsbad, CA).
The eyes were treated by submersion in RNA stabilizer (RNAlater
solution; Ambion, Inc., Austin, TX) within 2 to 12 hours postmor-
tem. RT-PCR was performed using standard methods with random
hexamers and reverse transcriptase (SuperScript II; Invitrogen).
Subsequent gene-specific PCR for all tested candidate genes was
performed using Taq polymerase (Platinum; Invitrogen) to validate
gene expression in human ocular tissue. The resulting PCR ampli-
cons were visualized on 2% agarose gels after electrophoresis and
staining with ethidium bromide.
Sequencing
Genomic DNA from two affected and two normal individuals were PCR-
amplified for regions covering the entire coding sequence and splice
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junctions of the genes CTAG2, GAB3, MPP1, F8Bver, FUNDC2, VBP1,
RAB39B, CLIC2, TMLHE, SYBL, IL9R, SPRY3, and CXYorf1. Detailed PCR
conditions for exons of each gene are available on request (Supplemen-
tary Table S1, http://www.iovs.org/lookup/suppl/doi:10.1167/iovs.
10-6815/-/DCSupplemental). Amplified PCR products were purified with
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FIGURE 1. Partial pedigrees of myo-
pia families UR006 (A) and UR077
(B). Filled symbols: affected individ-
uals; open symbols: normal individu-
als; question mark: deceased, data
not available; center dot: obligate car-
rier females. The DNA samples used
in the analysis are numbered under
each symbol in the pedigrees. Com-
mon haplotype among the affected
individual are boxed.
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(BigDye Terminators Sequencing Kit; Applied Biosytems, Inc. [ABI], Fos-
ter City, CA) in both directions with an automated genetic analysis system
(3100; ABI) and were analyzed with a commercial software program
package (Sequencer 4.1; Gene Codes, Ann Arbor, MI).
Electronic Database Information
The following sites were accessed during the research for this study:
The UCSC Human Genome Browser (http://genome.cse.ucsc.edu/,
University of California Santa Cruz); MERLIN (http://www.sph.umich.
edu/csg/abecasis/Merlin/, the University of Michigan, Ann Arbor, MI);
National Center for Biotechnology Information (http://www.ncbi.nlm.
nih.gov/, National Institutes of Health [NIH], Bethesda, MD); and Online
Mendelian Inheritance in Man (OMIM) (http://www.ncbi.nlm.nih.gov/
Omim/, NCBI, NIH).
RESULTS
All myopia subjects included in the analysis had high-grade myo-
pia in one or both the eyes (6.0 D) without any associated
anomalies, including color vision defect. All affected subjects
developed high-grade myopia before they were of school age.
None of the unrelated individuals in this family was observed with
any form of myopia. The results of two-point linkage analyses of
myopia families UR006 and UR077 and polymorphic microsatel-
lite markers covering the Xq28 genomic region at various recom-
bination fractions are shown in Table 1. A maximum combined
two-point LOD score of 5.3 was obtained for marker DXYS154,
which is located in the pseudoautosomal region of distal Xq28
(PAR2) at recombination fraction theta  0. Other markers in the
FIGURE 2. Fundus photographs of
individuals from family UR006: (A)
unaffected individual (6253) with
normal fundus and (B) affected individ-
ual (6247) with high-grade myopia
(12.5 D) with tessellation pattern.
TABLE 1. Combined Two-Point LOD Scores for MYP1 and Xq28 Markers for Families UR006 and UR077
Recombination Fractions
Physical
Position (Mb)Markers Family 0 0.01 0.05 0.10 0.20 0.30 0.40
GATA31E08 UR006  2.87 1.55 1.04 0.59 0.35 0.17
UR077  0.84 0.20 0.02 0.16 0.16 0.10
Combined  3.71 1.75 1.02 0.43 0.19 0.07 140.062
DXS1193 UR006  0.15 0.69 0.80 0.70 0.49 0.25
UR077 1.70 1.71 1.59 1.44 1.11 0.76 0.39
Combined  1.86 1.66 2.24 1.81 1.25 0.64 148.187
DXS8011 UR006  2.15 2.60 2.57 2.16 1.54 0.79
UR077 1.30 1.23 1.14 1.03 0.80 0.56 0.29
Combined  3.38 3.74 3.60 2.96 2.10 1.08 149.617
DXS8061 UR006  1.56 2.04 2.06 1.75 1.25 0.63
UR077 2.10 2.03 1.89 1.71 1.33 0.92 0.47
Combined  3.59 3.93 3.77 3.08 2.17 1.10 151.772
DXS15 UR006  2.15 2.60 2.57 2.16 1.54 0.79
UR077 1.70 1.71 1.59 1.44 1.11 0.76 0.38
Combined  3.86 4.19 4.01 3.27 2.30 1.17 152.128
DXS1177 UR006  2.15 2.60 2.57 2.16 1.54 0.79
UR077 2.00 1.98 1.84 1.67 1.29 0.88 0.45
Combined  4.13 4.44 4.24 3.45 2.42 1.24 152.285
DXS1073 UR006  1.38 1.87 1.89 1.60 1.13 0.58
UR077 2.00 2.01 1.87 1.69 1.31 0.90 0.46
Combined  3.39 3.74 3.58 2.91 2.03 1.04 152.547
F8i13 UR006 2.22 2.18 2.00 1.78 1.34 0.91 0.46
UR077 0.92 0.91 0.84 0.76 0.58 0.40 0.20
Combined 3.14 3.09 2.84 2.54 1.92 1.31 0.66 153.482
DXS8087 UR006 1.15 1.12 1.01 0.87 0.61 0.38 0.18
UR077 1.07 1.05 0.97 0.86 0.65 0.42 0.19
Combined 2.22 2.17 1.98 1.73 1.26 0.80 0.37 153.8
DXS1108 UR006 1.29 1.26 1.14 0.99 0.69 0.42 0.19
UR077 0.92 0.91 0.84 0.76 0.58 0.40 0.20
Combined 2.21 2.17 1.98 1.75 1.27 0.82 0.39 154.515
DXY154 UR006 3.99 3.91 3.59 3.19 2.33 1.42 0.57
UR077 1.31 1.27 1.13 0.96 0.62 0.33 0.11
Combined 5.30 5.18 4.72 4.15 2.95 1.75 0.68 154.731
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region (near but not within PAR2) that showed no recombination
with the phenotype included DXS1108, DXS8087, and F8i13.
However, recombination was observed between the phenotype and
markers GATA31E08, DXS1193, DXS8011, DXS8061, DXS15,
DXS1177, and DXS1073 for family UR006. Other X chromosome
markers that showed negative LOD scores are not shown. RT-PCR
results confirmed expression of all genes tested in human ocular
tissue (Fig. 3). Sequence analysis of known exons and splice
junctions of 13 positional candidate genes did not yield any
mutations in the exons and intron–exon boundaries for the af-
fected and normal individuals.
DISCUSSION
Myopia is a heterogeneous disorder and has a multifactorial etiol-
ogy in which both genetics and environment play important
roles. Seventeen loci50 with evidence of linkage for either high- or
low-grade myopia have been identified on various chromo-
somes.9,10,13–23,50,51 However, to date no convincing candidate
gene has been found to be mutated in myopia. In the only known
X-linked MYP1 family, affected males and homozygous females
exhibited myopia and color vision defect.9 The same family was
revisited by Young et al.13 to include additional subjects and
genealogic data using polymorphic microsatellite markers. All
affected males had high-grade myopia with protanopia and mild
cone dysfunction on electroretinogram testing, whereas carrier
females had normal findings in functional and structural ophthal-
mic evaluations. Zhang et al.10 mapped another X-linked myopia
locus (MYP13) to the Xq23-q25 region. In both studies,10,13 all
affected individuals had associated anomalies; however, in the
present two families (UR006 and UR077), all female carriers were
normal, and no affected male members had any associated anom-
alies, including color vision defect. Linkage analysis showed that
the disease locus maps to the previously identified region on
Xq289; however, haplotype analysis (Fig. 1A) revealed informative
recombination events in the affected individual III-42 (6256) of
family UR006 reduced the previously defined genomic interval of
6.8 cM at Xq27.3-Xq2813 to 1.4 cM, by flanking the proximal
marker at DXS1073 and the distal boundary at DXYS154. Marker
DXYS154 gave the highest combined LOD score at   0; how-
ever, no distal markers are available. Although families UR006 and
UR077 are of Indian origin, they belong to different ethnic groups.
Haplotype analysis from the Xq28-linked region of affected indi-
viduals did not find extensive common haplotypes shared be-
tween these two families, yet a few common identical alleles were
observed for selected markers. The MYP13 locus was excluded
by linkage and haplotype analysis for both the families.
This 1.25-Mb linked genomic region on Xq28 contains multi-
ple candidate genes for high-grade myopia, including CTAG2,
GAB3, MPP1, F8Bver, FUNDC2, VBP1, RAB39B, CLIC2, and
TMLHE, proximal to PAR2, and SYBL, IL9R, and SPRY3CXYorf1
in PAR2. Sequence analysis indicated that none of these genes is
involved in the pathogenesis of the MYP1 phenotype in both the
pedigrees. The absence of pathogenic polymorphic variants in the
coding regions of these genes indicates that the mutation may lie
in a regulatory region of one of these candidate genes, in another
gene, or in another functional element (conserved or not) within
the MYP1 region. It is also possible that the mutation is a dupli-
cation or a deletion within this region. However, a deletion of the
coding sequence of genes outside PAR2 is excluded, because we
successfully amplified all sequences in the males. There are genes in
the PAR2 region that are only expressed from the X-chromosome;
thus, they behave as X-linked recessive. HSPRY3 and SYBL1 are both
inactive on Y and are subject to X inactivation in humans.52 In
contrast, IL9R and CXYorf1 are expressed on Y and are not subject
to X inactivation.53,54 Identification of the mutant gene would po-
tentially provide significant insights into the molecular mechanisms
underlying the etiology of nonsyndromic myopia.
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